Cogent Biosciences, Inc. (COGT) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$40,375
Total Return
303.75%
CAGR
32.20%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +5.94% |
| Median | +0.43% |
| Best | +178.20% |
| Worst | -55.66% |
| % of Windows Positive | 50.5% |
1-Year (252 Trading Days)
| Average | +75.38% |
| Median | +23.47% |
| Best | +807.71% |
| Worst | -70.12% |
| % of Windows Positive | 63.1% |
3-Year (756 Trading Days)
| Average | +64.60% |
| Median | +21.30% |
| Best | +283.37% |
| Worst | -51.86% |
| % of Windows Positive | 75.2% |
Risk Metrics
| Maximum Drawdown | -76.34% |
| Average Drawdown | -32.96% |
| Drawdown Duration | 799 Trading Days |
| Sortino Ratio | 1.33 |
| Calmar Ratio | 0.42 |
| CVaR (5%) | -9.56% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -9.18% (-20.41% ann.) | $917.79 | $0.00 | $0.00 | $0.00 |
| 2025 | +355.38% | +$35538.35 | $0.00 | $0.00 | $0.00 |
| 2024 | +32.65% | +$3265.36 | $0.00 | $0.00 | $0.00 |
| 2023 | -49.14% | $4913.50 | $0.00 | $0.00 | $0.00 |
| 2022 | +34.73% | +$3473.21 | $0.00 | $0.00 | $0.00 |
| 2021 | -23.60% | $2359.75 | $0.00 | $0.00 | $0.00 |
| 2020 | +289.93% | +$28993.30 | $0.00 | $0.00 | $0.00 |
| 2019 | -83.64% | $8363.65 | $0.00 | $0.00 | $0.00 |
| 2018 partial | -60.40% (-70.52% ann.) | $6039.60 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | March 29, 2018 – February 19, 2020 | -93.03% | -75.49% | $9303.33 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -42.82% | -99.83% | $4282.08 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +412.56% | +1286.74% | +$41255.58 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -21.00% | -20.03% | $2099.51 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +45.96% | +49.41% | +$4595.94 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -17.36% | -9.78% | $1736.06 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +205.78% | +92.57% | +$20578.18 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.